Tie Liu Shi

Shanghai Lansheng (Group) Corp. is an investment holding company ultimately controlled by the City of Shanghai. The company is based in Shanghai, China.

Konfoong Biotech International Co., Ltd. is a high-tech bio-information technology enterprise based in China. The Chinese company has built numerous pathology teleconsultation platforms, including several provincial centers nationwide, and its digital pathology products have been implemented in almost 1,000 hospitals across the country. Konfoong Biotech has also been actively incorporating artificial intelligence technology to promote product innovation and has launched over 10 artificial intelligence-aided pathology diagnosis projects, such as cervical fluid-based cytology, liver pathology, kidney pathology, and breast pathology, to develop intelligent pathology-aided diagnosis systems. The company was founded in 2011 by Bing Xian Liu, who has been the CEO since then.

Shanghai Boendengte Technology Co., Ltd. is a company that provides high-quality and cost-effective oral products through independent innovation. The company is based in Shanghai, China and was founded in 2009 by Fang Jun Tian. The Chinese company offers a range of oral equipment and consumables, including earl imaging products, simo dental microscopy, bomei star comprehensive treatment channel, corel correction products, iezplanting series, yirui m3 pipe series, and other products. The company is also the agent of the northern and Italian laser nationwide in the vdw of Germany.

Shanghai KingBo Cultural Creative Co., Ltd. engages in the development, production, and sale of brand terminal image displays. It offers terminal image displays, terminal image integrated construction services, terminal image design and project management services, and installation services. The company was founded on May 21, 2009 and is headquartered in Shanghai, China.

Ustar Biotechnologies (Hangzhou) Ltd. develops and manufactures molecular diagnostic products. Its products include DNA extraction, TB testings, STD testings and DNA detection. The company was founded by Qimin You and Michael Hu in 2005 and is headquartered in Hangzhou, China.

Shanghai Zerun Biotechnology Co., Ltd. engages in the development, commercialization, and industrialization of new recombinant human vaccine products. It develops recombinant vaccines such as preventive cervical cancer vaccines, and recombinant enterovirus 71 virus-like particle and therapeutic vaccines. The company was founded on May 7, 2003 and is headquartered in Shanghai, China.